|
nasdaq:ntra
|
1051903
|
Apr 21st, 2024 12:00AM
|
Natera
|
97K
|
3309
|
Open
|
|
Apr 20th, 2024 11:52PM
|
Apr 20th, 2024 11:52PM
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
|
Open
|
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
|
Open
|
13011A McCallen Pass
|
Austin
|
Texas
|
US
|
78753
|
|
Natera
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:ntra
|
1051903
|
Apr 20th, 2024 12:00AM
|
Natera
|
97K
|
3309
|
Open
|
|
Apr 19th, 2024 11:49PM
|
Apr 20th, 2024 05:24PM
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
|
Open
|
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
|
Open
|
13011A McCallen Pass
|
Austin
|
Texas
|
US
|
78753
|
|
Natera
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:ntra
|
1051903
|
Apr 19th, 2024 12:00AM
|
Natera
|
96K
|
3296
|
Open
|
|
Apr 18th, 2024 11:56PM
|
Apr 18th, 2024 11:56PM
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
|
Open
|
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
|
Open
|
13011A McCallen Pass
|
Austin
|
Texas
|
US
|
78753
|
|
Natera
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:ntra
|
1051903
|
Apr 18th, 2024 12:00AM
|
Natera
|
96K
|
3297
|
Open
|
|
Apr 18th, 2024 12:05AM
|
Apr 18th, 2024 06:44PM
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
|
Open
|
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
|
Open
|
13011A McCallen Pass
|
Austin
|
Texas
|
US
|
78753
|
|
Natera
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:ntra
|
1051903
|
Apr 17th, 2024 12:00AM
|
Natera
|
96K
|
3289
|
Open
|
|
Apr 16th, 2024 11:47PM
|
Apr 17th, 2024 03:10PM
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
|
Open
|
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
|
Open
|
13011A McCallen Pass
|
Austin
|
Texas
|
US
|
78753
|
|
Natera
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:ntra
|
1051903
|
Apr 16th, 2024 12:00AM
|
Natera
|
95K
|
3285
|
Open
|
|
Apr 15th, 2024 11:43PM
|
Apr 16th, 2024 11:26AM
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
|
Open
|
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
|
Open
|
13011A McCallen Pass
|
Austin
|
Texas
|
US
|
78753
|
|
Natera
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:ntra
|
1051903
|
Apr 15th, 2024 12:00AM
|
Natera
|
95K
|
3285
|
Open
|
|
Apr 14th, 2024 11:38PM
|
Apr 15th, 2024 05:07PM
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
|
Open
|
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
|
Open
|
13011A McCallen Pass
|
Austin
|
Texas
|
US
|
78753
|
|
Natera
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:ntra
|
1051903
|
Apr 14th, 2024 12:00AM
|
Natera
|
95K
|
3283
|
Open
|
|
Apr 13th, 2024 11:27PM
|
Apr 13th, 2024 11:27PM
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
|
Open
|
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
|
Open
|
13011A McCallen Pass
|
Austin
|
Texas
|
US
|
78753
|
|
Natera
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:ntra
|
1051903
|
Apr 13th, 2024 12:00AM
|
Natera
|
95K
|
3284
|
Open
|
|
Apr 12th, 2024 11:19PM
|
Apr 13th, 2024 11:52AM
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
|
Open
|
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
|
Open
|
13011A McCallen Pass
|
Austin
|
Texas
|
US
|
78753
|
|
Natera
|
Health Care
|
Health Care Equipment & Services
|
|
nasdaq:ntra
|
1051903
|
Apr 12th, 2024 12:00AM
|
Natera
|
95K
|
3281
|
Open
|
|
Apr 11th, 2024 11:24PM
|
Apr 12th, 2024 08:48AM
|
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives.
Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.
Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients.
#TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy.
Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team.
Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California.
Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes.
https://www.natera.com/privacy/
|
Open
|
Non-Invasive Prenatal Testing (NIPT), Single gene diseases, Preimplantation Genetic Screening (PGS)/Diagnosis (PGD), Biopsy training, Multi-Disease Carrier Screening, Bioinformatics, Miscarriage testing, Genetic counseling, Non-invasive paternity testing, Genetics, colorectal cancer, Oncology, Transplant, Kidney Transplant, Cancer, Transplant Rejection, and ctDNA
|
Open
|
13011A McCallen Pass
|
Austin
|
Texas
|
US
|
78753
|
|
Natera
|
Health Care
|
Health Care Equipment & Services
|